World Acceptance Corporation reported strong Q3 fiscal 2026 results with 25% growth in new customer outstanding ledger and 5.4% organic customer base expansion. The company improved gross yields by 84 basis points year-over-year and reduced share count by 11% through repurchases. However, the expanded new customer portfolio required an $8 million additional loan loss provision, and management expects incentive compensation expenses to decline in future quarters as temporary overstaffing adjustments are made.

World Acceptance reported Q1 FY 2026 earnings with mixed results: revenue slightly increased to $132.5 million, but earnings per share dropped significantly to $0.25, missing analyst expectations. The company faced challenges with higher operating expenses and credit loss provisions.

Bread Financial (BFH) stands to gain from solid consumer spending, credit sales performance and a robust capital position, offset by escalating expenses.

Ally Financial's (ALLY) efforts to diversify the revenue base will likely aid profits. Elevated costs due to inorganic growth efforts may hurt the bottom line.

Mr. Cooper, World Acceptance and EZCORP have been highlighted in this Industry Outlook article.

Though concerns about rising prices and weak asset quality are likely to hurt the Zacks Consumer Loans industry, the digitization of operations, decent loan demand and easing lending standards will aid Cooper Group (COOP), World Acceptance (WRLD) & EZCORP (EZPW).

World Acceptance (WRLD) delivered earnings and revenue surprises of 40% and 6.89%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Enova International (ENVA) delivered earnings and revenue surprises of 11.70% and 5.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Mr. Cooper, World Acceptance and EZCORP are part of the Zacks Industry Outlook article.

Though concerns about rising prices and weak asset quality are likely to hurt the Zacks Consumer Loans industry, the digitization of operations and easing lending standards are expected to support Cooper Group (COOP), World Acceptance (WRLD) & EZCORP (EZPW).

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company’s quarterly sales came in at $215.42 million versus expectations of $204.36 million. Freshpet shares gained 15.5% to $106.29 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Akili, Inc. (NASDAQ: AKLI) shares jumped 126% to $0.5009 after the company reported positive results from Shionogi's Phase 3 clinical trial of localized version of Akili's EndeavorRx® for Pediatric ADHD patients in Japan. ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) climbed 126% to $1.81 after surging over 30% on Friday. MicroCloud Hologram Inc. (NASDAQ: HOLO) gained 107% to $13.71 after tumbling 40% on Friday. Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 54.6% to $0.49. Interactive Strength Inc. (NASDAQ: TRNR) surged 32.2% to $0.8701 after the company announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR. Agiliti, Inc. (NASDAQ: AGTI) gained 29.4% to $9.89 after the company announced it will be taken private by THL Partners. Krystal Biotech, Inc. (NASDAQ: KRYS) surged 28.8% to $143.34 after the company reported better-than-expected financial results. R1 RCM Inc. (NYSE: RCM) surged 26.7% to $14.06 after the company received an acquisition offer for the company valued at $13.75 per share. Butterfly Network, Inc. (NASDAQ: BFLY) gained 26.3% to $1.2880. Altimmune, Inc. (NASDAQ: ALT) surged 22.1% to $11.24. Milestone Pharmaceuticals Inc. (NASDAQ: MIST) gained 21.3% to $2.10 after the company announced plans to resubmit the New Drug Application (NDA) for etripamil to the U.S. Food and Drug ...

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak quarterly sales. Surgery Partners posted adjusted earnings of 44 cents per share, versus market estimates of 38 cents per share. The company’s quarterly sales came in at $735.40 million missing expectations of $741.40 million, according to data from Benzinga Pro. Surgery Partners shares tumbled 7.8% to $30.43 on Monday. Here are some other big stocks recording losses in today’s session. Intuitive Machines, Inc. (NASDAQ: LUNR) dipped 25.1% to $7.18 ...